The global Vinpocetine market continues to demonstrate robust growth, with the Vinpocetine Glucose Injection segment valued at $96 million in 2025​ and projected to reach $137 million by 2032, expanding at a steady CAGR of 5.1%​ . This naturally derived compound from the periwinkle plant (Catharanthus roseus) serves critical functions in cerebrovascular health and cognitive enhancement. Understanding the global buyer landscape for Vinpocetine is essential for suppliers targeting this expanding market, which benefits from increasing global aging populations, rising awareness of brain health, and growing demand for nootropic supplements. This comprehensive analysis provides an in-depth examination of Vinpocetine’s buyer ecosystem, identifying key purchasing industries, major corporate consumers, geographic hotspots, and…